Law firms Cravath and Kirkland ride pharma wave to win places on $5.8bn Abbott-Alere deal Legal Business · 1 February 2016 · 1 min read Corporate and M&A Cravath, Swaine & Moore Kirkland & Ellis Already two of the big winners from the merger bonanza in the pharmaceuticals sector, Cravath, Swaine & Moore and Kirkland & Ellis have won mandates advising on the $5.8bn purchase of diagnostic testing company Alere by Abbott Laboratories.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryEQT’s biggest deals: which firms are winning the trophy mandates in Europe?Law firmsWill Lewallen14 Jul 2026Trading Places: Paul Hastings picks up Cahill private credit co-head as Wilmer and Perkins Coie see exits in San FranciscoLaw firmsEliza Winter8 Jul 2026‘M&A is back with a bang’ – global elite dominate deal rankings in best-ever H1Law firmsKate Peacock3 Jul 2026Baker McKenzie matches Macfarlanes with £150k NQ salary hike as Pallas and Katten also bump City payLaw firmsTom Cox20 Jul 2026Global elite firms take it away as Uber agrees €13bn acquisition of Delivery HeroLaw firmsKate Peacock17 Jul 2026Magic circle duo engineer £4.1bn sale of British manufacturing PLC Rotork to ABBLaw firmsKate Peacock16 Jul 2026Revolving doors: Simpson Thacher, Latham, Sidley lead New Year London movesLaw firmsAnna Huntley9 Jan 2025Five partners vie to succeed Hoyland as Simmons managing partnerLaw firmsTom Cox7 Jan 2025‘Seize every opportunity’ – Paul Hastings partner Reena Gogna on City law, Suits and poetryLaw firmsAnna Huntley7 Jan 2025